This Amendment No. 2 ("Amendment No. 2") to Schedule 13D amends and supplements the statement on 13D originally filed on January 26, 2018 and Amendment No. 1 thereto filed on February 22, 2019 relating to the common shares, $0.001 par value (the "Common Stock"), of Genocea Biosciences, Inc. (the "Issuer") having its principal executive office at Cambridge Discovery Park, 100 Acorn Park Drive, 5th Floor, Cambridge, Massachusetts 02140.
Certain terms used but not defined in this Amendment No. 2 have the meanings assigned thereto in the Schedule 13D (including Amendment No. 1 thereto). Except as specifically provided herein, this Amendment No. 2 does not modify any of the information previously reported on the Schedule 13D (including Amendment No. 1 thereto).
This statement is being filed by:
(a) New Enterprise Associates 16, L.P. ("NEA 16"), NEA Partners 16, L.P. ("NEA Partners 16"), which is the sole general partner of NEA 16; and NEA 16 GP, LLC ("NEA 16 LLC" and, together with NEA Partners 16, the "Control Entities"), which is the sole general partner of NEA Partners 16; and
(b) Peter J. Barris ("Barris"), Forest Baskett ("Baskett"), Ali Behbahani ("Behbahani"), Carmen Chang ("Chang"), Anthony A. Florence, Jr. ("Florence"), Mohamad H. Makhzoumi ("Makhzoumi"), Joshua Makower ("Makower"), David M. Mott ("Mott"), Scott D. Sandell ("Sandell"), Peter W. Sonsini ("Sonsini") and Paul Walker ("Walker") (together, the "Managers"). The Managers are the managers of NEA 16 LLC.
The persons named in this Item 2 are referred to individually herein as a "Reporting Person" and collectively as the "Reporting Persons."
The address of the principal business office of NEA 16 and each Control Entity is New Enterprise Associates, 1954 Greenspring Drive, Suite 600, Timonium, MD 21093. The address of the principal business office of each of Barris, Behbahani and Mott is New Enterprise Associates, 5425 Wisconsin Avenue, Suite 800, Chevy Chase, MD 20815. The address of the principal business office of Baskett, Chang, Makhzoumi, Makower, Sandell, Sonsini and Walker is New Enterprise Associates, 2855 Sand Hill Road, Menlo Park, California 94025. The address of the principal business office of Florence is New Enterprise Associates, 104 5th Avenue, 19th Floor, New York, NY 10001.
The principal business of NEA 16 is to invest in and assist growth-oriented businesses located principally in the United States. The principal business of NEA Partners 16 is to act as the sole general partner of NEA 16. The principal business of NEA 16 LLC is to act as the sole general partner of NEA Partners 16. The principal business of each of the Managers is to manage the Control Entities, NEA 16 and a number of affiliated partnerships with similar businesses.
During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding or has been a party to a civil proceeding ending in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
NEA 16 LLC is a limited liability company organized under the laws of the State of Delaware. NEA 16 and NEA Partners 16 are limited partnerships organized under the laws of the State of Delaware. Each of the Managers is a United States citizen.
On June 24, 2019, the Issuer completed the closing of an underwritten offering of 10,500,000 shares of Common Stock (the "Offering"). At such closing of the Offering, NEA 16 purchased an aggregate of 2,857,142 shares of the Issuer's Common Stock at the purchase price of $3.50 per share (the "NEA 16 Shares"). Prior to the Offering, NEA 16 held 4,368,534 shares of the Issuer's Common Stock (the "Prior NEA 16 Shares"), a Class A warrant (the "NEA 16 Class A Warrant") to purchase, subject to certain limitations, up to an aggregate of 1,562,500 shares of the Issuer's Common Stock, exercisable immediately (the "NEA 16 Class A Warrant Shares"), and a Class B warrant (the "NEA 16 Class B Warrant") to purchase, subject to certain limitations, up to an aggregate of 155,441 shares of the Issuer's Common Stock, exercisable immediately (the "NEA 16 Class B Warrant Shares" and, together with the NEA 16 Shares, the Prior NEA 16 Shares, the NEA 16 Class A Warrant, the NEA 16 Class A Warrant Shares and the NEA 16 Class B Warrant, the "Securities"). NEA 16 now holds a total of 7,225,676 shares of the Issuer's Common Stock and warrants to purchase 1,717,941 shares of the Issuer's Common Stock.
The working capital of NEA 16 was the source of the funds for the purchase of the Securities. No part of the purchase price of the Securities was represented by funds or other consideration borrowed or otherwise obtained for the purpose of acquiring, holding, trading or voting the Securities.